News & Updates

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

03 Jun 2020 by

Once-daily 14 mg oral semaglutide yields greater reduction in HbA1c and body weight than weekly 0.75 mg subcutaneous dulaglutide and is well tolerated in a Japanese population with uncontrolled type 2 diabetes (T2D), according to the PIONEER 10 study.

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

03 Jun 2020

Psychiatric comorbidities frequent among transgender teens

03 Jun 2020 by

There is a high incidence of psychiatric comorbidities among gender nonconforming teenagers, with about two-thirds and one-third experiencing depression and anxiety, respectively, according to a study presented at ENDO 2020.

Psychiatric comorbidities frequent among transgender teens

03 Jun 2020

Long-term radioiodine treatment effective in toxic multinodular goiter

03 Jun 2020

Treatment with 15 mCi of radioiodine (RAI) leads to low hypothyroidism rates in adult patients with toxic multinodular goiter (TMNG), with high cure rates and significant volume reduction, according to a study. This effect persists in the long term.

Long-term radioiodine treatment effective in toxic multinodular goiter

03 Jun 2020

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

03 Jun 2020

The glucagon-like peptide-1 (GLP-1) receptor agonist (RA) dulaglutide shows highly consistent effectiveness on glycated haemoglobin (HbA1c) and body weight reduction in patients with type 2 diabetes (T2D), reveals a study. Its effectiveness remains significant even in subgroups of patients poorly represented in randomized controlled trials (RCTs).

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

03 Jun 2020

Glucagon effective for hypoglycaemia in T1DM regardless of administration route

03 Jun 2020

In conscious type 1 diabetes mellitus (T1DM) patients, administering glucagon intranasally is as effective at resolving hypoglycaemia as administering it via intramuscular/subcutaneous injections, according to the results of a meta-analysis.

Glucagon effective for hypoglycaemia in T1DM regardless of administration route

03 Jun 2020

Relugolix combo therapy preserves bone mass in women with heavy period

02 Jun 2020 by

Combining the oral GnRH* receptor antagonist relugolix together with oestradiol and the progestin norethindrone helps protect against bone loss induced by oestrogen deprivation associated with the use of GnRH receptor antagonist monotherapy for treating heavy menstrual bleeding, according to the LIBERTY studies released during the ACOG 2020 Meeting.

Relugolix combo therapy preserves bone mass in women with heavy period

02 Jun 2020

$Obesity confers no protection against fractures in older men$

Obesity confers no protection against fractures in older men

02 Jun 2020

Older men who are obese do not appear to have a lower incidence of fracture compared with their nonobese counterparts, a study has shown in a study.

Obesity confers no protection against fractures in older men

02 Jun 2020

Conventional dose still better than reduced dose insulin for hyperkalaemia

02 Jun 2020

A recent study has shown that conventional dose insulin remains more effective than reduced dose regular insulin at baseline serum potassium levels >6 mmol/L in the treatment of hyperkalaemia.

Conventional dose still better than reduced dose insulin for hyperkalaemia

02 Jun 2020

Sugary drinks may raise bad cholesterol levels

28 May 2020 by

Daily intake of sugar-sweetened beverages was associated with elevated triglyceride levels and lower HDL cholesterol levels, both of which are risk factors for cardiovascular disease (CVD), according to the Framingham Heart Study with up to 23 years of follow-up.

Sugary drinks may raise bad cholesterol levels

28 May 2020

Long working hours may up hypothyroidism risk

28 May 2020 by

A study from South Korea, presented at ENDO 2020, suggested that individuals who work long hours may be at risk of developing hypothyroidism.

Long working hours may up hypothyroidism risk

28 May 2020

News & Updates

Filter by Specialty:

Specialty:

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

Psychiatric comorbidities frequent among transgender teens

Psychiatric comorbidities frequent among transgender teens

Long-term radioiodine treatment effective in toxic multinodular goiter

Long-term radioiodine treatment effective in toxic multinodular goiter

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

Glucagon effective for hypoglycaemia in T1DM regardless of administration route

Glucagon effective for hypoglycaemia in T1DM regardless of administration route

Relugolix combo therapy preserves bone mass in women with heavy period

Relugolix combo therapy preserves bone mass in women with heavy period

Obesity confers no protection against fractures in older men

Obesity confers no protection against fractures in older men

Conventional dose still better than reduced dose insulin for hyperkalaemia

Conventional dose still better than reduced dose insulin for hyperkalaemia

Sugary drinks may raise bad cholesterol levels

Sugary drinks may raise bad cholesterol levels

Long working hours may up hypothyroidism risk

Long working hours may up hypothyroidism risk